How Private Healthcare Can Solve Noncommunicable Diseases: Washington Post Live Conference

(3BL Media / theCSRfeed) September 12, 2011 - Sharing the Responsibility: Noncommunicable Diseases: September 14th, 8:30 a.m.-2:00 p.m.

At the conference, Mark Kramer will discuss the approach of using Public and Private Partnerships to solve the NCD crisis during Panel III: 10:45 a.m.-11:45 a.m. EST.  The full panel includes:

• Dr. John Lechleiter, President and CEO, Eli Lilly and Company

• Herb Riband, Vice President of External Affairs International, Medtronic; Chair, Public Affairs Network, Eucomed

• Mark Kramer, Co-Founder and Managing Director, FSG; Senior Fellow, Harvard Kennedy School of Government

• Rep. Diana DeGette, Co-Chair, Congressional Diabetes Caucus

• The Honorable Nils Daulaire, MD, MPH, Director, Office of Global Health Affairs, Department of Health and Human Services

• (Moderator) Mary Jordan, Washington Post Live

Watch the LIVE webcast on 9/14 at 10:45 a.m. EST.

FSG16703

Tracy J. Sims, Senior Advisor of Global Health Programs, and Vice-President of the Lilly Foundation at Eli Lilly and Company, writes for FSG's Social Impact blog.  His post, "It's About People We Will Never Meet," addresses the NCDs issue in conjunction with the UN General Assembly on NCDs next week (September 19-20).  In his post, Tracy announces the Lilly NCD Partnership.  The partnership will explore and research comprehensive models of care for people who have diabetes through partnership with leading global health organizations and report as soon as possible about what the findings are so others can evaluate and replicate effective approaches.  

Read the Tracy Sim's guest post on FSG's Social Impact blog.